Systemic Healing: Can be used to control inflammation and help the body heal as a whole
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
Who should avoid BPC-157
In research contexts, subcutaneous GHK-Cu injection is being explored for its systemic effects particularly its potential to deliver anti-inflammatory, tissue-regenerative, and gene-expression-modulating effects to tissues beyond the skin, including muscles, joints, internal organs, and the central nervous system
Evidence signal Longevity research 7 source-backed citations are connected to this page
doi:10.1371/journal.pone.0033944 Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ et al (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial